ROYAL BANK OF CANADA - AEVI GENOMIC MEDICINE INC ownership

AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 45 filers reported holding AEVI GENOMIC MEDICINE INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AEVI GENOMIC MEDICINE INC
ValueSharesWeighting
Q4 2019$0
-100.0%
500
-75.0%
0.00%
Q4 2018$1,000
-50.0%
2,000
-4.3%
0.00%
Q3 2018$2,0000.0%2,089
+4.4%
0.00%
Q2 2018$2,000
-50.0%
2,0000.0%0.00%
Q1 2018$4,000
+100.0%
2,000
-1.2%
0.00%
Q4 2017$2,000
-33.3%
2,0250.0%0.00%
Q3 2017$3,0000.0%2,025
+1.2%
0.00%
Q2 2017$3,000
-50.0%
2,000
-36.8%
0.00%
Q1 2017$6,000
-68.4%
3,165
-14.7%
0.00%
Q4 2016$19,0003,7100.00%
Other shareholders
AEVI GENOMIC MEDICINE INC shareholders Q3 2018
NameSharesValueWeighting ↓
Birchview Capital, LP 128,000$20,0000.01%
ARTHUR M. COHEN & ASSOCIATES, LLC 64,390$10,0000.00%
Verity Asset Management, Inc. 17,000$3,0000.00%
VANGUARD GROUP INC 1,252,050$201,0000.00%
Kistler-Tiffany Companies, LLC 690$00.00%
BNP PARIBAS FINANCIAL MARKETS 2$00.00%
BARCLAYS PLC 69$00.00%
OneDigital Investment Advisors LLC 31,110$4,0000.00%
BANK OF AMERICA CORP /DE/ 4,365$1,0000.00%
WELLS FARGO & COMPANY/MN 15,384$2,0000.00%
View complete list of AEVI GENOMIC MEDICINE INC shareholders